Tianjin Tianyao Pharmaceuticals Co., Ltd.
600488
Rank in Stocks
#9901
Tianjin Tianyao Pharmaceuticals Co., Ltd. is a Chinese enterprise primarily... Tianjin Tianyao Pharmaceuticals Co., Ltd. is a Chinese enterprise primarily engaged in the research, manufacturing, and export of active pharmaceutical ingredients (APIs) across the Asian market. The company's core product offerings include APIs and formulated drugs for corticosteroid, cardio cerebrovascular, and analgesic applications. Its extensive portfolio of bulk drug substances encompasses numerous compounds such as dexamethasone and its various salts and esters, prednisone, prednisolone, flucinonide, halcinonide, triamcinolone and its derivatives, clobetasol propionate, betamethasone, and methylprednisolone. Based in Tianjin, China, Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE: 600488) operates as a subsidiary of Jinhushen Biomedical Technology Co., Ltd.
Share Price
$0.70757722
Last synced: 2026-11-13
Market Cap
$772.59M
Change (1 day)
-4.26%
Change (1 year)
12.26%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488)
Category
Healthcare
Operating Margin for Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488)
Operating Margin as of November 2026 TTM: 3.40%
According to Tianjin Tianyao Pharmaceuticals Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 3.40%. At the end of 2025 the company had an operating margin of 6.53%.
Operating Margin history for Tianjin Tianyao Pharmaceuticals Co., Ltd. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 3.40% | -47.93% |
| 2025 | 6.53% | -6.98% |
| 2024 | 7.02% | 56.70% |
| 2023 | 4.48% | 135.79% |
| 2022 | 1.90% | -51.16% |
| 2021 | 3.89% | -8.47% |
| 2020 | 4.25% | -49.64% |
| 2019 | 8.44% | -7.76% |
| 2018 | 9.15% | -4.09% |
| 2017 | 9.54% | 6.95% |
| 2016 | 8.92% | 49.41% |
| 2015 | 5.97% | 18.69% |
| 2014 | 5.03% | 66.56% |
| 2013 | 3.02% | -64.92% |
| 2012 | 8.61% | 21.78% |
| 2011 | 7.07% | -21.18% |
| 2010 | 8.97% | 8.99% |
| 2009 | 8.23% | 30.84% |
| 2008 | 6.29% | 41.67% |
| 2007 | 4.44% | -50.72% |
| 2006 | 9.01% | -37.43% |
| 2005 | 14.40% | 13.74% |
| 2004 | 12.66% | -20.78% |
| 2003 | 15.98% | -10.48% |
| 2002 | 17.85% | -0.78% |
| 2001 | 17.99% | 14.44% |
| 2000 | 15.72% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.69% | -94.21% |
DE
|
|
| 19.68% | -94.21% |
DE
|
|
| 13.26% | -96.10% |
JP
|
|
| 17.08% | -94.98% |
CH
|
|
| 10.53% | -96.90% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Tianjin Tianyao Pharmaceuticals Co., Ltd.'s operating margin
What is Tianjin Tianyao Pharmaceuticals Co., Ltd.'s operating margin?
Tianjin Tianyao Pharmaceuticals Co., Ltd.'s operating margin is 3.40%, as of Nov 2026.
What was Tianjin Tianyao Pharmaceuticals Co., Ltd.'s operating margin in 2025?
In 2025, Tianjin Tianyao Pharmaceuticals Co., Ltd.'s operating margin was 6.53%, compared with 7.02% in 2024.
How has Tianjin Tianyao Pharmaceuticals Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Tianjin Tianyao Pharmaceuticals Co., Ltd.'s operating margin was highest in 2024 (7.02%) and lowest in 2022 (1.90%).
How does Tianjin Tianyao Pharmaceuticals Co., Ltd.'s operating margin compare with similar companies?
Tianjin Tianyao Pharmaceuticals Co., Ltd.'s operating margin (3.40%) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with 19.69%.